SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-24-025995
Filing Date
2024-05-31
Accepted
2024-05-31 14:38:55
Documents
3
Period of Report
2024-05-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1717180725.html 3  
1 FORM 3 wk-form3_1717180725.xml 3 2191
2 EX-24 bischofbergernorbert-sec.htm EX-24 4285
3 bischofbergernorbert-sec001.jpg GRAPHIC 214736
  Complete submission text file 0001628280-24-025995.txt   303862
Mailing Address 333 LAKESIDE DR C/O GILEAD SCIENCES, INC. FOSTER CITY CA 94404
Business Address
BISCHOFBERGER NORBERT W (Reporting) CIK: 0001190273 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39083 | Film No.: 241009128

Mailing Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158
Business Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Issuer) CIK: 0001706431 (see all company filings)

IRS No.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)